Cargando…

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study

AIM: To determine whether pioglitazone is associated with an increased risk of bladder cancer among Indian type 2 diabetic patients. METHODS: A retrospective data analysis of 2222 type 2 diabetic patients was conducted. The study subjects were divided into two equal groups: 1111 pioglitazone users a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Sunil, Gupta, Kavita, Ravi, R., Mehta, Vinita, Banerjee, Samar, Joshi, Shashank, Saboo, Banshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566345/ https://www.ncbi.nlm.nih.gov/pubmed/26425474 http://dx.doi.org/10.4103/2230-8210.163187

Ejemplares similares

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
por: Balaji, V., et al.
Publicado: (2014)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

Association of Educational, Occupational and Socioeconomic Status with Cardiovascular Risk Factors in Asian Indians: A Cross-Sectional Study
por: Gupta, Rajeev, et al.
Publicado: (2012)

Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study
por: Shamanna, Paramesh, et al.
Publicado: (2021)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study
por: Saboo, Banshi, et al.
Publicado: (2021)

Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Gujarat cohort of the A(1)chieve study
por: Saboo, Banshi, et al.
Publicado: (2013)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
por: DONG, YOUHONG, et al.
Publicado: (2016)

A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone
por: Agrawal, Prabhat, et al.
Publicado: (2021)

Key elements of successful intensive therapy in patients with type 1 diabetes
por: Saboo, Banshi
Publicado: (2015)

Indian Injection Technique Study: Population Characteristics and Injection Practices
por: Kalra, Sanjay, et al.
Publicado: (2017)

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
por: Neumann, A., et al.
Publicado: (2012)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
por: Korhonen, Pasi, et al.
Publicado: (2016)

Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional
por: Kalra, Sanjay, et al.
Publicado: (2017)

Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross–sectional study
por: Gupta, Rajeev, et al.
Publicado: (2015)

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
por: Lewis, James D., et al.
Publicado: (2011)

Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
por: Jin, Sang-Man, et al.
Publicado: (2014)

Pioglitazone use and Parkinson’s disease: a retrospective cohort study in Taiwan
por: Wu, Hsiu-Feng, et al.
Publicado: (2018)

Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study
por: Thacker, Hemant, et al.
Publicado: (2016)

Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
por: Singh, Awadhesh Kumar, et al.
Publicado: (2019)

Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study
por: Saboo, Banshi, et al.
Publicado: (2015)

Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
por: Qu, Hua, et al.
Publicado: (2017)

Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
por: Tseng, Chin-Hsiao
Publicado: (2012)

Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
por: Tseng, Chin-Hsiao
Publicado: (2018)

Recent Advances in Silver Nanostructured Substrates for Plasmonic Sensors
por: Gahlaut, Shashank K., et al.
Publicado: (2022)

Bhramari Pranayama – A simple lifestyle intervention to reduce heart rate, enhance the lung function and immunity
por: Trivedi, Gunjan Y., et al.
Publicado: (2021)

RSSDI’s Defeat Diabetes Campaign: India takes a major leap in the direction of diabetes care capital of the world
por: Saboo, Banshi, et al.
Publicado: (2021)

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018)

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis
por: Tseng, Chin-Hsiao
Publicado: (2022)

Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Tseng, Chin-Hsiao
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q8mombk9gtn8tp0hjl8kgsb9rn